Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Mise à jour : Il y a 4 ans
Référence : NCT00523042

Femme et Homme

Extrait

This trial is conducted in Europe, Asia, Oceania and the United States of America (USA). This is a one-year clinical trial to compare the safety of inhaled preprandial human insulin to subcutaneous insulin aspart in subjects with type 1 or 2 diabetes and asthma.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2 ,Asthma


Liens